ArticleBMC cardiovascular disorders2026
Temporal changes of oxidative stress and ferroptosis-associated biomarkers in STEMI patients undergoing primary PCI and their correlation with myocardial reperfusion injury.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMyocardial ischemia-reperfusion injury in ST-elevation myocardial infarction (STEMI) involves complex mechanisms, including oxidative stress and ferroptosis, but the timing and relationship of these processes with cardiac injury markers remain unclear. This study investigated how oxidative stress and ferroptosis-associated biomarkers change over time and their correlations with cardiac injury markers in STEMI patients undergoing primary percutaneous coronary intervention (PCI).
methodsA prospective cohort of 25 STEMI patients undergoing primary PCI was studied. Serum levels of cardiac injury biomarkers (Troponin I, CK-MB) and oxidative stress/ferroptosis markers (superoxide dismutase [SOD], total antioxidant capacity [TAC], glutathione peroxidase [GPx], lipid peroxidation products [LPO], serum iron, and ferritin) were measured at pre-PCI, and at 6, 12, 24, and 48 h post-PCI. Temporal trends and Pearson correlations between these biomarkers were analyzed.
resultsMarkers of oxidative stress and ferroptosis-associated biomarkers demonstrated distinct time-dependent patterns post-reperfusion: SOD and TAC peaked early (6-12 h), while GPx initially decreased. LPO levels peaked at 6 h. Serum iron transiently declined, and ferritin showed a temporary increase at 6-12 h. Activities of antioxidant enzymes (SOD, GPx, TAC) showed inverse correlations with peak and cumulative cardiac injury markers in this pilot cohort, whereas higher LPO and iron showed positive correlations with greater myocardial damage observed here. CK-MB associations were stronger than those with Troponin I in this pilot cohort.
conclusionIn this pilot cohort, oxidative stress and ferroptosis-associated biomarkers showed rapid early changes after reperfusion in STEMI patients undergoing primary PCI, correlating with myocardial injury extent (stronger correlations with CK-MB than troponin I). These findings suggest early oxidative stress and iron dysregulation as potential therapeutic targets for reperfusion injury, warranting confirmation in larger studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.